Watchlist Price Alert

Pieris Pharmaceuticals In... (PIRS)

NASDAQ: PIRS · Real-Time Price · USD

13.60

-2.51 (-15.58%)

At close: Dec 13, 2024, 9:00 PM

Pieris Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	42.81M	25.9M	31.42M	29.32M	46.28M	29.1M	25.27M	5.83M
Cost of Revenue	41.8M	2.78M	2.37M	46.53M	55M	n/a	n/a	n/a
Gross Profit	1.01M	23.12M	29.05M	-17.21M	-8.72M	29.1M	25.27M	5.83M
Operating Income	-29.76M	-43.47M	-51.83M	-33.92M	-27.16M	-30.83M	-14.59M	-22.76M
Interest Income	1.85M	721K	4K	511K	1.71M	1.96M	152K	2.32K
Pretax Income	-24.54M	-33.28M	-45.74M	-37.07M	-25.47M	-27.07M	-16.54M	-22.64M
Net Income	-24.54M	-31.25M	-43.37M	-37.23M	-23.75M	-26.75M	-17.65M	-22.8M
Selling & General & Admin	16.85M	16.39M	16.59M	16.71M	18.44M	18.44M	17.58M	8.89M
Research & Development	41.8M	52.98M	66.66M	46.53M	55M	41.49M	22.29M	19.7M
Other Expenses	13.91M	-8.17M	-3.69M	-3.66M	-26K	1.8M	-2.1M	119.5K
Operating Expenses	72.57M	61.2M	79.56M	63.24M	73.44M	59.93M	39.87M	28.59M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	1.95M	2.32K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	72.57M	61.2M	79.56M	63.24M	73.44M	59.93M	39.87M	28.59M
Income Tax Expense	n/a	-2.02M	-2.37M	164K	-1.71M	-312K	1.1M	161.97K
Shares Outstanding (Basic)	1.13M	927.15K	806.84K	681.01K	632.81K	663.51K	549.14K	521.41K
Shares Outstanding (Diluted)	1.13M	927.15K	806.84K	681.01K	632.81K	663.51K	549.14K	521.41K
EPS (Basic)	-21.8	-33.71	-53.75	-54.67	-37.54	-40.32	-32.14	-43.73
EPS (Diluted)	-21.8	-33.71	-53.75	-54.67	-37.54	-40.32	-32.14	-43.73
EBITDA	-22.76M	-30.5M	-43.37M	-31.61M	-26.12M	-30.26M	-14.22M	-22.4M
EBIT	-24.54M	-35.3M	-48.15M	-33.92M	-27.16M	-30.83M	-14.59M	-22.76M
Depreciation & Amortization	1.78M	2.78M	2.37M	2.13M	1.04M	570K	369K	361.38K